Core Viewpoint - The company plans to establish a wholly-owned subsidiary, Shanghai Shenke Gas Turbine Technology Co., Ltd., to capitalize on opportunities in the gas turbine industry and expand its high-end equipment manufacturing sector [1] Group 1: Company Strategy - The registered capital for the new subsidiary will be 30 million RMB, focusing on research, production, and sales related to gas turbines [1] - The establishment of the subsidiary aligns with the company's long-term development strategy, aiming to extend the industrial chain and cultivate new profit growth points [1] Group 2: Operational Focus - The subsidiary will collaborate with the Shanghai R&D Center to promote the commercialization of gas turbine sliding bearing systems and partner with leading domestic and international manufacturers [1] - Funding for the investment will come from the company's own or self-raised funds, ensuring no adverse impact on the current financial status [1] Group 3: Regulatory and Market Considerations - The investment decision was approved during the first meeting of the seventh board of directors on December 19, 2025, and does not require shareholder approval [1] - The establishment of the subsidiary is subject to approval from relevant authorities, and the company may face uncertainties related to macroeconomic and industry environments in the future [1]

人民财讯8月19日电，莱茵生物（002166）8月19日在互动平台表示，国内市场方面，公司所申报的甜菊 糖苷（酶转化法）RebM2作为食品添加剂新品种，其征求意见稿公示阶段已于8月14日结束，公司积极 推动其后续的审批工作；海外市场方面，今年2月公司RebM2已通过美国FDAGRAS认证，可在美国食 品饮料市场合法销售。RebM2产品由公司研发团队独家开发，未来有望成为公司新的利润增长点。 ...